Synthesis using ring closure metathesis and effect on nucleoside transport of a (N)-methanocarba S-(4-nitrobenzyl)thioinosine derivative

Organic Letters

Volumn 3, Issue 4, 2001, Pages 597-599

  Lee, Kyeong ^a   Cass, Carol ^b   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4-NITROBENZYLTHIOINOSINE; CYCLOPENTANE DERIVATIVE; CYCLOPENTANONE; DRUG DERIVATIVE; MERCAPTOPURINE RIBOSIDE; NITROBENZYLTHIOINOSINE; NUCLEOTIDE;

ARTICLE; CATALYSIS; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION; DRUG EFFECT; HUMAN; METABOLISM; STRUCTURE ACTIVITY RELATION; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CATALYSIS; CELLS, CULTURED; CYCLIZATION; CYCLOPENTANES; HUMANS; MOLECULAR STRUCTURE; NUCLEOTIDES; STRUCTURE-ACTIVITY RELATIONSHIP; THIOINOSINE;

EID: 0035932075     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol006999c     Document Type: Article

References (28)

1. Fredholm, B. B.; Abbracchio, M. P.; Burnstock, G.; Dubyak, G. R.; Harden, T. K.; Jacobson, K. A.; Schwabe, U.; Williams, M. Trends Pharmacol. Sci. 1997, 18, 79. Jacobson, K. A.; Knutsen, L. J. S. P1 and P2 purine and pyrimidine receptors. In Handbook of Experimental Pharmacology; Abbracchio, M. P., Williams, M. Eds.; Springer: Berlin, 2001; in press.
2. Fredholm, B. B.; Abbracchio, M. P.; Burnstock, G.; Dubyak, G. R.; Harden, T. K.; Jacobson, K. A.; Schwabe, U.; Williams, M. Trends Pharmacol. Sci. 1997, 18, 79. Jacobson, K. A.; Knutsen, L. J. S. P1 and P2 purine and pyrimidine receptors. In Handbook of Experimental Pharmacology; Abbracchio, M. P., Williams, M. Eds.; Springer: Berlin, 2001; in press.
3. (a) Rodriguez, J. B.; Marquez, V. E.; Nicklaus, M. C.; Mitsuya, H.; Barch, J. J., Jr. J. Med. Chem. 1994, 37, 3389.
4. (b) Marquez, V. E.; Siddiqui, M. A.; Ezzitouni, A.; Russ, P.; Wang, J.; Wagner, R. W.; Matteucci, M. D. J. Med. Chem. 1996, 39, 3739.
5. (c) Marquez, V. E.; Ezzitouni, A.; Russ, P.; Siddiqui, M. A.; Ford, H., Jr.; Feldman, R. J.; Mitsuya, H.; George, C.; Barch, J. J., Jr. J. Am. Chem. Soc. 1998, 120, 2780.
6. (d) Moon, H. R.; Kim H. O.; Chun, M. W.; Jeong L. S.; Marquez, V. E. J. Org. Chem. 1999, 63, 4733.
7. Jacobson, K. A.; Ji, X.-D.; Li, A. H.; Melman, N.; Siddiqui, M. A.; Shin, K. J.; Marquez, V. E.; Ravi, R. G. J. Med. Chem. 2000, 43, 2196.
8. Nandanan, E.; Jang, S. Y.; Moro, S.; Kim, H. O.; Siddiqui, M. A.; Russ, P.; Marquez, V. E.; Busson, R., Herdewijn, P.; Harden, T. K.; Boyer, J. L.; Jacobson, K. A. J. Med. Chem. 2000, 43, 829.
9. (a) Crawford, C. R.; Ng, C. Y. C.; Noel, L. D.; Belt, J. A. J. Biol. Chem. 1990, 265, 9732.
10. (b) Dagnino, L.; Bennett, L. L., Jr.; Paterson, A. R. P. J. Biol. Chem. 1991, 266, 6308.
11. (c) Baldwin, S. A.; Mackey, J. R.; Cass, C. E.; Young, J. D. Mol. Med. Today 1999, 5, 216.
12. (a) Nguyen, S. T.; Johnson, L. K.; Grubbs, R. H.; Ziller, J. W. J. Am. Chem. Soc. 1992, 114, 3974.
13. (b) Grubbs, R. H.; Miller, S. J. Acc. Chem. Res. 1995, 28, 446.
14. (c) Schmalz, H.-G. Angew. Chem., Int. Ed. Engl. 1995, 34, 1833.
15. (d) Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413.
16. Ohira, S.; Sawamoto, T.; Yamato, M. Tetrahedron Lett. 1995, 36, 1537.
17. Jeong, L. S.; Marquez, V. E.; Yuan, C.-S.; Borchardt, R. T. Heterocycles 1995, 41, 2651.
18. 3OD): 8.79 (s, 1H), 8.74 (s, IH), 8.78, 8.15 (2s, 2H) 7.76, 7.64 (2s, 2H), 4.46-4.99 (m, 3H), 4.87 (s, 1H), 4.72 (s, 2H), 4.24 (m, IH), 3.89 (m, 1H), 1.56 (m, 1H), 0.93 (m, 1H). HRMS (FAB): calcd 430.1185, found 430.1171.
19. Bellas, M.; Tuleen, D. L.; Field, L. J. Org. Chem. 1967, 32, 2590.
20. (a) Medich, J. R.; Kunnen, K. B.; Johnson, C. R. Tetrahedron Lett. 1987, 28, 4131.
21. (b) Marquez, V. E.; Lim, M.-I.; Tseng, C. K.-H.; Markovac, A.; Priest, M. A.; Khan, M. S.; Kaskar, B. J. Org. Chem. 1988, 53, 5709.
22. (a) Altman, K.-H.; Kesselring, R.; Francotte, E.; Rihs, G. Tetrahedron Lett. 1994, 35, 2331.
23. (b) Siddiqui, M. A.; Ford, H., Jr.; George, C.; Marquez, V. E. Nucleosides Nucleotides 1996, 15, 235.
24. "es" refers to equilibrative inhibitor-sensitive and "ei" refers to equilibrative inhibitor-insensitive systems.
25. Cass, C. E.; King, K. M.; Montano, J. T.; Janowska-Wieczorek, A. Cancer Res. 1992, 52, 5879.
26. Crawford, C. R.; Ng, C. Y.; Ullman, B.; Belt, J. A. Biochim. Biophys. Acta 1990, 1024, 289.
27. Boumah, C. E.; Hogue, D. L.; Cass, C. E. Biochem. J. 1992, 288, 987.
28. Seepersaud, M.; Al-Abed Y. Tetrahedron Lett. 2000, 41, 7801.